EFFECTS OF LOSARTAN AND ANTIRETROVIRAL REGIMEN CONTAINING RALTEGRAVIR IN FIBROSIS INFLAMMATION MEDIATORS, CARDIOVASCULAR RISK AND NEUROCOGNITIVE DISORDERS IN HIV INFECTED PATIENTS PREVIOUSLY EFFECTIVELY TREATED: